Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.955
-0.105 (-9.88%)
At close: Apr 28, 2026, 4:00 PM EDT
0.950
-0.005 (-0.56%)
After-hours: Apr 28, 2026, 7:38 PM EDT
SNTI Stock Forecast
SNTI's stock price has decreased by -81% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for SNTI stock have an average target of 8.50, with a low estimate of 5.00 and a high estimate of 12. The average target predicts an increase of 789.77% from the current stock price of 0.96.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 30, 2026.
Analyst Ratings
The average analyst rating for SNTI stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +1,051.47% | Mar 30, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +1,260.83% | Dec 9, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $6 | Buy | Initiates | $6 | +528.07% | Nov 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +1,156.15% | Oct 14, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +1,156.15% | Aug 8, 2025 |
Financial Forecast
Revenue This Year
n/a
from 22.00K
Revenue Next Year
n/a
EPS This Year
-1.12
from -2.73
EPS Next Year
-0.91
from -1.12
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||||
| Avg | n/a | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -0.71 | -0.57 | ||||
| Avg | -1.12 | -0.91 | ||||
| Low | -1.35 | -1.23 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.